OncoPharm cover image

Mirvetuximab Soravtansine

OncoPharm

00:00

Phase III Forward‑1: Negative Trial Results

John asks whether confirmatory trials exist and discusses Forward‑1, a negative phase 3 showing no PFS or OS benefit versus chemotherapy.

Play episode from 14:16
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app